Current Studies

> Back to Media
> Back to Services
> Newsletters
> Current News

MCA conducts clinical trials and pharmaceutical studies for various conditions and medications. Year round we perform both short term and long term clinical trials for pharmaceutical research studies.

Below are some current clinical trials and studies. If you would like to participate please be sure you read and meet all the qualifications associated.

Attention Smokers & Ex-Smokers

Participants needed for a new study with Spiriva, an inhaled maintenance medication for breathing problems associated with Chronic Obstructive Pulmoanry Disease (COPD). Must be at least 40 years of age. If you currently smoke or have smoked in the past you may qualify to participate in this clincal research study being conducted. While participating in this study eligible persons will receive study related medical exams and study medications at no cost while participating in the study. Compensations will aso be provided for time and travel.

Please contact us for more information, 713-407-3076.

COPD Prevention

A new inhaled COPD preventive medication. This study lasts 1 year. The main study doctor is Dr. Richard Pohil.

Overactive Bladder

An approved medication for OVERACTIVE BLADDER targeting patients with frequent nighttime urination. This study lasts 14 weeks. The main study doctor is Dr. Miguel Franco.

Atrial Fibrillation

A new ANTICOAGULANT for patients with ATRIAL FIBRILLATION. Everyone on this study received either Coumadin (warfarin) or the study medication. Your clotting time is checked monthly at our office at no costs to you. This study will last 1 to 3 years. The main study doctor is Dr. Miguel Franco.

For more information and sign-up, contact our Research Study Coordinator: Paula Gentry (713) 407-3076

Thank you for interest in Memorial Clinical Associates.